Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Infected”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00108862
What this trial is testing

Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis

Who this might be right for
HIV InfectionTuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 809
Testing effectiveness (Phase 2)Ended earlyNCT01026727
What this trial is testing

Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy

Who this might be right for
HIV Infections
Myrexis Inc. 2
Large-scale testing (Phase 3)WithdrawnNCT00011128
What this trial is testing

Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00000912
What this trial is testing

A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 475
Large-scale testing (Phase 3)Study completedNCT02178592
What this trial is testing

Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 113
Testing effectiveness (Phase 2)Study completedNCT00002395
What this trial is testing

Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)

Who this might be right for
HIV InfectionsLeukoencephalopathy, Progressive Multifocal
SmithKline Beecham 54
Post-approval studies (Phase 4)Temporarily pausedNCT00143728
What this trial is testing

3TC or No 3TC for HIV With 3TC Resistance

Who this might be right for
HIV Infections
University of British Columbia 152
Early research (Phase 1)Study completedNCT00002107
What this trial is testing

A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients

Who this might be right for
HIV Infections
Chiron Corporation
Post-approval studies (Phase 4)Study completedNCT01838772
What this trial is testing

HCV Treatment in HIV Co-Infected Patients in Asia

Who this might be right for
Hepatitis CHIV
amfAR, The Foundation for AIDS Research 188
Not applicableUnknownNCT00797381
What this trial is testing

Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia

Who this might be right for
HIV InfectionHemophilia A
Shanghai Public Health Clinical Center 100
Not applicableStudy completedNCT00100581
What this trial is testing

Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 2
Early research (Phase 1)Study completedNCT01300988
What this trial is testing

Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg Dose

Who this might be right for
HIV Infection
University of Pennsylvania 18
Testing effectiveness (Phase 2)Ended earlyNCT00300573
What this trial is testing

Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIs

Who this might be right for
HIV InfectionsHuman Immunodeficiency Virus
Incyte Corporation 250
Early research (Phase 1)Study completedNCT00000879
What this trial is testing

The Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 48
Large-scale testing (Phase 3)Study completedNCT00708162
What this trial is testing

Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir

Who this might be right for
HIV Infection
Gilead Sciences 724
Not applicableStudy completedNCT02216591
What this trial is testing

Improving Memory Performance by Applying Cognitive Training

Who this might be right for
HIV
Duke University 33
Post-approval studies (Phase 4)Study completedNCT05264662
What this trial is testing

Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant Women

Who this might be right for
dTap Vaccine
Farzanah Laher 511
Testing effectiveness (Phase 2)Ended earlyNCT03198559
What this trial is testing

Combination Latency Reversal With High Dose Disulfiram Plus Vorinostat in HIV-infected Individuals on ART

Who this might be right for
HIV Infections
University of Melbourne 5
Early research (Phase 1)Study completedNCT02388594
What this trial is testing

A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients

Who this might be right for
Human Immunodeficiency Virus (HIV)
University of Pennsylvania 14
Testing effectiveness (Phase 2)Study completedNCT02212379
What this trial is testing

Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRAL

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 170
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation